de Thé, Hugues
Inserm,
France
2024 Rank: 25234
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 826 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25234 | 23182 |
| Total Cites | 877 | 1009 |
| H-index | 13 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 52 | 54 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 145 | 156 |
| Number of Single+First+Last Authored Papers | 131 | 131 |
| Total Cites to Single+First+Last Authored Papers | 459 | 529 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 624 | 646 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.56 |
| Self-Citation Percentage |
13.08%
|
|
de Thé, Hugues
Collège de France,
France
2023 Rank: 19445
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 695 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19445 | 20451 |
| Total Cites | 984 | 1116 |
| H-index | 15 | 15 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 57 | 60 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 183 | 192 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 531 | 578 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 677 | 726 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.54 |
| Self-Citation Percentage |
11.83%
|
|
de Thé, Hugues
Université Paris Cité,
France
2022 Rank: 17978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 678 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17978 | 19160 |
| Total Cites | 958 | 1109 |
| H-index | 15 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 50 | 52 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 155 | 164 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 536 | 588 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 661 | 712 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.56 |
| Self-Citation Percentage |
13.62%
|
|
de Thé, Hugues
Collège de France,
France
2021 Rank: 14949
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 548 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14949 | 14990 |
| Total Cites | 1509 | 1710 |
| H-index | 20 | 22 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 92 | 94 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 266 | 280 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 888 | 966 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1001 | 1068 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.60 |
| Self-Citation Percentage |
11.75%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.